The estimated Net Worth of Bio Exagen, L.P.H.I.G. Gpii... is at least $5.14 Milion dollars as of 23 September 2019. Bio Gpii owns over 425,000 units of Exagen Inc stock worth over $5,139,644 and over the last 5 years Bio sold XGN stock worth over $0.
Bio has made over 1 trades of the Exagen Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Bio bought 425,000 units of XGN stock worth $5,950,000 on 23 September 2019.
The largest trade Bio's ever made was buying 425,000 units of Exagen Inc stock on 23 September 2019 worth over $5,950,000. On average, Bio trades about 425,000 units every 0 days since 2019. As of 23 September 2019 Bio still owns at least 1,696,252 units of Exagen Inc stock.
You can see the complete history of Bio Gpii stock trades at the bottom of the page.
Over the last 5 years, insiders at Exagen Inc have traded over $8,628,989 worth of Exagen Inc stock and bought 556,568 units worth $6,283,309 . The most active insiders traders include James L L Tullis, Bio Exagen, L.P.H.I.G. Gpii... a Jeffrey Thomas Elliott. On average, Exagen Inc executives and independent directors trade stock every 48 days with the average trade being worth of $109,189. The most recent stock trade was executed by John Aballi on 16 May 2024, trading 40,401 units of XGN stock currently worth $77,570.
exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.
Exagen Inc executives and other stock owners filed with the SEC include: